R D Fechtner

Summary

Affiliation: New Jersey
Country: USA

Publications

  1. pmc Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost
    Robert D Fechtner
    Glaucoma Division, University of Medicine and Dentistry New Jersey, Newark, NJ, USA
    Clin Ophthalmol 5:945-53. 2011
  2. ncbi request reprint Evolving global risk assessment of ocular hypertension to glaucoma
    Robert D Fechtner
    Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 07103, USA
    Curr Opin Ophthalmol 18:104-9. 2007
  3. ncbi request reprint Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results
    Robert D Fechtner
    Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey New Jersey Medical School, 90 Bergen Street, Newark, NJ 07103, USA
    Arch Ophthalmol 124:1257-62. 2006
  4. ncbi request reprint Anterior uveitis associated with latanoprost
    R D Fechtner
    Department of Ophthalmology, University of Medicine and Dentistry of New Jersey, Newark 07103, USA
    Am J Ophthalmol 126:37-41. 1998
  5. ncbi request reprint Fixed combinations of topical glaucoma medications
    Robert D Fechtner
    Institute of Ophthalmology and Visual Science New Jersey Medical School UMDNJ, Newark, New Jersey, USA
    Curr Opin Ophthalmol 15:132-5. 2004
  6. ncbi request reprint Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials
    Robert D Fechtner
    Glaucoma Division, New Jersey Medical School, UMDNJ, Newark, NJ 07101 1709, USA
    Acta Ophthalmol Scand 82:42-8. 2004
  7. ncbi request reprint Efficacy of the dorzolamide/timolol fixed combination versus latanoprost in the treatment of ocular hypertension or glaucoma: combined analysis of pooled data from two large randomized observer and patient-masked studies
    Robert D Fechtner
    Glaucoma Division, New Jersey Medical School, UMNDJ, Newark, NJ, USA
    J Ocul Pharmacol Ther 21:242-9. 2005
  8. ncbi request reprint Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
    Jess T Whitson
    Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    J Glaucoma 13:168-73. 2004
  9. ncbi request reprint Use of fixed-dose combination drugs for the treatment of glaucoma
    Albert S Khouri
    Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA
    Drugs Aging 24:1007-16. 2007
  10. ncbi request reprint Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications
    Robert D Fechtner
    Department of Ophthalmology, New Jersey Medical School, Newark, NJ, USA
    Cornea 29:618-21. 2010

Collaborators

Detail Information

Publications25

  1. pmc Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost
    Robert D Fechtner
    Glaucoma Division, University of Medicine and Dentistry New Jersey, Newark, NJ, USA
    Clin Ophthalmol 5:945-53. 2011
    ..2%/timolol 0.5% compared with timolol 0.5% at peak and trough effect when used as therapy adjunctive to latanoprost 0.005% in patients with glaucoma or ocular hypertension who require additional IOP lowering...
  2. ncbi request reprint Evolving global risk assessment of ocular hypertension to glaucoma
    Robert D Fechtner
    Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 07103, USA
    Curr Opin Ophthalmol 18:104-9. 2007
    ..To discuss current knowledge of global risk assessment in ocular hypertension...
  3. ncbi request reprint Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results
    Robert D Fechtner
    Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey New Jersey Medical School, 90 Bergen Street, Newark, NJ 07103, USA
    Arch Ophthalmol 124:1257-62. 2006
    ..To evaluate the ocular safety of short-term use of vigabatrin to treat cocaine and/or methamphetamine addiction...
  4. ncbi request reprint Anterior uveitis associated with latanoprost
    R D Fechtner
    Department of Ophthalmology, University of Medicine and Dentistry of New Jersey, Newark 07103, USA
    Am J Ophthalmol 126:37-41. 1998
    ..To report the association of anterior uveitis with the use of latanoprost...
  5. ncbi request reprint Fixed combinations of topical glaucoma medications
    Robert D Fechtner
    Institute of Ophthalmology and Visual Science New Jersey Medical School UMDNJ, Newark, New Jersey, USA
    Curr Opin Ophthalmol 15:132-5. 2004
    ..In this review the authors discuss the principles of fixed combination therapy and examine the existing fixed combinations...
  6. ncbi request reprint Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials
    Robert D Fechtner
    Glaucoma Division, New Jersey Medical School, UMDNJ, Newark, NJ 07101 1709, USA
    Acta Ophthalmol Scand 82:42-8. 2004
    ..To compare the efficacy of the fixed dorzolamide 2%/timolol 0.5% combination (COSOPT) versus latanoprost 0.005% (XALATAN)...
  7. ncbi request reprint Efficacy of the dorzolamide/timolol fixed combination versus latanoprost in the treatment of ocular hypertension or glaucoma: combined analysis of pooled data from two large randomized observer and patient-masked studies
    Robert D Fechtner
    Glaucoma Division, New Jersey Medical School, UMNDJ, Newark, NJ, USA
    J Ocul Pharmacol Ther 21:242-9. 2005
    ..6 mmHg), and mean IOP at each time point during the day. By the measures used in this analysis, the dorzolamide/timolol combination and latanoprost were equally effective at lowering IOP in patients with ocular hypertension or glaucoma...
  8. ncbi request reprint Comparison of the safety and efficacy of dorzolamide 2% and brimonidine 0.2% in patients with glaucoma or ocular hypertension
    Jess T Whitson
    Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    J Glaucoma 13:168-73. 2004
    ..To compare the intraocular pressure (IOP) reduction between dorzolamide 2% and brimonidine 0.2% in primary open-angle glaucoma (POAG) or ocular hypertension (OHT)...
  9. ncbi request reprint Use of fixed-dose combination drugs for the treatment of glaucoma
    Albert S Khouri
    Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA
    Drugs Aging 24:1007-16. 2007
    ..The clinician must make individualised assessments when weighing the convenience of these medications against their limitations for specific patients...
  10. ncbi request reprint Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications
    Robert D Fechtner
    Department of Ophthalmology, New Jersey Medical School, Newark, NJ, USA
    Cornea 29:618-21. 2010
    ..To determine the prevalence of ocular surface disease (OSD) in patients with glaucoma using topical intraocular pressure (IOP)-lowering therapy...
  11. ncbi request reprint Comparison of digital and film stereo photography of the optic nerve in the evaluation of patients with glaucoma
    Albert S Khouri
    Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey New Jersey Medical School, Newark, New Jersey 07103, USA
    Telemed J E Health 12:632-8. 2006
    ..Digital images correlated well with film for SSP of the optic nerve in glaucoma...
  12. ncbi request reprint The uniocular drug trial and second-eye response to glaucoma medications
    Tony Realini
    Department of Ophthalmology, West Virginia University, Box 9193, Morgantown, WV 26505, USA
    Ophthalmology 111:421-6. 2004
    ..To determine if the intraocular pressure (IOP) reduction observed in a uniocular trial correlates with the IOP reduction seen in the fellow eye when the same medication is then administered to the second eye of patients with glaucoma...
  13. ncbi request reprint DICOM transmission of simultaneous stereoscopic images of the optic nerve in patients with glaucoma
    Albert S Khouri
    Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ 07103, USA
    J Telemed Telecare 13:337-40. 2007
    ..The differences between transmitted and received images were not significant. Clinical interpretation of digital stereoscopic images of glaucomatous optic nerves appears to be unaffected by DICOM capture and transmission...
  14. doi request reprint Short-term complications of intravitreal injection of triamcinolone acetonide
    Daniel B Roth
    Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
    Retina 28:66-70. 2008
    ..To describe the short-term complications associated with intravitreal triamcinolone acetonide (IVTA) injection in the treatment of posterior segment disorders...
  15. ncbi request reprint Antifibrotics and wound healing in glaucoma surgery
    Paul J Lama
    Glaucoma Division, New Jersey Medical School, Newark 07103, USA
    Surv Ophthalmol 48:314-46. 2003
    ..Future directions and recommendations regarding use of these agents are available and an introduction to newer wound modulating agents such as anti-transforming growth factor beta 2 is presented...
  16. ncbi request reprint Software-assisted optic nerve assessment for glaucoma tele-screening
    Albert S Khouri
    Institute of Ophthalmology and Visual Science, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 07103, USA
    Telemed J E Health 14:261-5. 2008
    ..Accurate determination of CDR is important in tele-screening for vision-threatening diseases, and can aid in identifying subjects with suspicious ONH in need of specialty eye care...
  17. ncbi request reprint The Proview phosphene tonometer fails to measure ocular pressure accurately in clinical practice
    Tara L Alvarez
    Department of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA
    Ophthalmology 111:1077-85. 2004
    ..To evaluate the Proview Eye Pressure Monitor as a medical instrument and as a technique for enabling a patient to obtain an accurate measure of his or her intraocular pressure (IOP)...
  18. ncbi request reprint Risk assessment in the management of patients with ocular hypertension
    Robert N Weinreb
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, CA 92093 0946, USA
    Am J Ophthalmol 138:458-67. 2004
    ....
  19. ncbi request reprint Corneal thickness measurement in the management of primary open-angle glaucoma: a report by the American Academy of Ophthalmology
    David K Dueker
    Ophthalmology 114:1779-87. 2007
    ..To evaluate published literature to assess whether central corneal thickness (CCT) is a risk factor for the presence, development, or progression of glaucomatous optic nerve damage related to primary open-angle glaucoma (POAG)...
  20. pmc Optic nerve head and retinal nerve fiber layer analysis: a report by the American Academy of Ophthalmology
    Shan C Lin
    Ophthalmology 114:1937-49. 2007
    ..To evaluate the current published literature on the use of optic nerve head (ONH) and retinal nerve fiber layer (RNFL) measurement devices in diagnosing open-angle glaucoma and detecting progression...
  21. ncbi request reprint An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma
    David S Friedman
    Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Am J Ophthalmol 138:S19-31. 2004
    ..To critically review the existing literature concerning risk factors for progression of ocular hypertension and glaucoma to assist in assigning levels of risk for individual patients...
  22. ncbi request reprint Automated perimetry: a report by the American Academy of Ophthalmology
    Maria F Delgado
    Ophthalmology 109:2362-74. 2002
    ..The purpose of this document is to summarize and evaluate the effectiveness of new automated perimetry tests and algorithms in diagnosing glaucoma and detecting disease progression...
  23. ncbi request reprint 56,000 ways to treat glaucoma
    Tony Realini
    Ophthalmology 109:1955-6. 2002
  24. ncbi request reprint Screening and diabetes mellitus
    Albert S Khouri
    Ophthalmology 114:398-9; author reply 399-400. 2007
  25. ncbi request reprint Detecting age-related macular degeneration: technologies are best compared when standardized
    Albert S Khouri
    Arch Ophthalmol 123:1157; author reply 1157-8. 2005